SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318771-04-000002
Filing Date
2004-03-02
Accepted
2004-03-01 20:52:33
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 GENENTECH, INC. - FORM 10-K FOR PERIOD ENDING DECEMBER 31, 2003 dna-10k_2003.htm 10-K 1135406
3 1991 EMPLOYEE STOCK PLAN, AS AMENDED ON APRIL 23, 2003. dna-ex10_10.htm EX-10.10 12471
4 AMENDED AND RESTATED BACKUP FACILITY AGREEMENT AND AMENDMENT TO OTHER OPERATIVE dna-ex10_16.htm EX-10.16 23605
5 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS. dna-ex23_1.htm EX-23.1 1722
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( dna-ex31_1.htm EX-31.1 5213
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( dna-ex31_2.htm EX-31.2 5570
8 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT T dna-ex32_1.htm EX-32.1 4028
  Complete submission text file 0000318771-04-000002.txt   1190953
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-09813 | Film No.: 04640913
SIC: 2834 Pharmaceutical Preparations